Gregory W. Albers
Researcher Next ID · RN-026114
Researcher · Medicine
Palo Alto, Belgium
- Works count
- 1,073
- Citation count
- 87,780
- H-index
- 136
- i10-index
- 535
Research interests
Publications
Trial of Endovascular Thrombectomy for Large Ischemic Strokes
New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2214403
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1713973
One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
New England Journal of Medicine · 2016 · 10.1056/nejmoa1412981
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1415061
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)60584-5
Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke
Stroke · 2013 · https://doi.org/10.1161/strokeaha.113.001972
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study
The Lancet Neurology · 2012 · 10.1016/s1474-4422(12)70203-x
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial
The Lancet · 2012 · 10.1016/s0140-6736(12)61299-9
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
New England Journal of Medicine · 2012 · 10.1056/nejmoa1009639
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
The Lancet · 2010 · 10.1016/s0140-6736(10)60491-6
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Stroke · 2010 · 10.1161/str.0b013e3181f7d043
Definition and Evaluation of Transient Ischemic Attack
Stroke · 2009 · 10.1161/strokeaha.108.192218
Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
New England Journal of Medicine · 2008 · 10.1056/nejmoa0805002
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
New England Journal of Medicine · 2008 · 10.1056/nejmoa0804593
Antithrombotic Therapy in Atrial Fibrillation
CHEST Journal · 2008 · 10.1378/chest.08-0678
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke · 2006 · 10.1161/01.str.0000199147.30016.74
Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study
Annals of Neurology · 2006 · 10.1002/ana.20976
Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
JAMA · 2005 · 10.1001/jama.293.6.690
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)
Stroke · 2004 · 10.1161/01.str.0000149938.08731.2c
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials
The Lancet · 2004 · 10.1016/s0140-6736(04)15692-4
Transient Ischemic Attack — Proposal for a New Definition
New England Journal of Medicine · 2002 · 10.1056/nejmsb020987
A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
New England Journal of Medicine · 2001 · 10.1056/nejmoa011258
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA · 2000 · 10.1001/jama.283.9.1145
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset
JAMA · 1999 · 10.1001/jama.282.21.2019
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
CHEST Journal · 1998 · 10.1378/chest.114.5_supplement.683s
Current projects
No projects listed.